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https://doi.org/10.1016/j.stemcr.2020.03.017SUMMARYNaive and primed human pluripotent stem cells (hPSC) provide valuable models to study cellular and molecular developmental
processes. The lack of detailed information about cell-surface protein expression in these two pluripotent cell types prevents an under-
standing of how the cells communicate and interact with theirmicroenvironments. Here, we used plasmamembrane profiling to directly
measure cell-surface protein expression in naive and primed hPSC. This unbiased approach quantified over 1,700 plasmamembrane pro-
teins, including those involved in cell adhesion, signaling, and cell interactions. Notably, multiple cytokine receptors upstream of JAK-
STAT signaling were more abundant in naive hPSC. In addition, functional experiments showed that FOLR1 and SUSD2 proteins are
highly expressed at the cell surface in naive hPSC but are not required to establish human naive pluripotency. This study provides a
comprehensive stem cell proteomic resource that uncovers differences in signaling pathway activity and has identified new markers
to define human pluripotent states.INTRODUCTION
Recent reports have identified conditions that can stabilize
human pluripotent stem cells (hPSC) in different states
that hold distinct molecular and functional properties
(Guo et al., 2017; Takashima et al., 2014; Theunissen
et al., 2014). At the two ends of the pluripotency spectrum
are naive hPSC that recapitulate the pre-implantation
human epiblast, and conventionally grown primed hPSC
that more closely align to the post-implantation epiblast
(Dong et al., 2019). These cell types can provide informa-
tive models to study the earliest stages of human develop-
ment and the control of pluripotent cell identity (Davidson
et al., 2015; Weinberger et al., 2016).
Naive and primed hPSC differ substantially in their
signaling responses, cell morphology, and growth require-
ments in culture, suggesting that they interact with and
respond differently to their microenvironments (Collier
and Rugg-Gunn, 2018). Although genomic and transcrip-
tomic studies have provided a rich molecular characteriza-
tion of naive hPSC, there is a lack of detailed information
about cell-surface protein expression in these cells that
could inform about this relationship. Cell-surface proteins
are of particular interest due to their critical roles in cell
communication and interactions (da Cunha et al., 2009),
and their expression is typically more variable between
cell types than other protein classes (Schwanhäusser
et al., 2011). A quantitativemeasurement of the cell-surface
proteome could provide information about how cells972 Stem Cell Reports j Vol. 14 j 972–988 j May 12, 2020 j ª 2020 The Auth
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growth and differentiation, which are critical to the func-
tion of pluripotent cell types. Profiling cell-surface proteins
in naive hPSC could also identify markers that would help
with their characterization and aid methods to accurately
distinguish them from primed hPSC and other cell types
that are required to resolve complex populations during
cell state transitions (Collier and Rugg-Gunn, 2018; Good-
win et al., 2020; Trusler et al., 2018). In addition, strategies
for enriching or eliminating target cell types within a
population often rely on the known expression patterns
of cell-surface markers and mapping surface proteomes is,
therefore, a prerequisite for applying these approaches in
naive and primed hPSC (Ben-David et al., 2013; Choo
et al., 2008; Tang et al., 2011).
The correlation between transcript levels and protein
abundance is particularly low in relation to cell-surface pro-
teins (Boheler et al., 2014; Liu et al., 2016; Rugg-Gunn et al.,
2012; Schwanhäusser et al., 2011), and also gene expression
profiles do not provide information on post-translational
modifications that can often provide epitopes for cell-
type-specific antibodies (Ojima et al., 2015). Antibody-
based screens in naive and primed hPSC have identified
shared and state-specific cell-surface marker expression,
although this approach is reliant on the availability of suit-
able antibodies (Collier et al., 2017). Accordingly, the direct
measurement and quantitation of cell-surface proteins is
desirable. Advances inmass spectrometry (MS)-basedprote-
omic technologies have enabled the broadmeasurement ofor(s).
ns.org/licenses/by/4.0/).
Figure 1. Cell-Surface Proteomics of Naive and Primed Human Pluripotent Stem Cells
(A) Plasma membrane profiling and mass spectrometry to quantify cell-surface protein expression in hPSC. Naive H9 hPSC were maintained
in t2iLGö on Matrigel-coated plates and primed H9 hPSC were maintained in TeSR-E8 on Vitronectin-coated plates. TMT, tandemmass tags.
(legend continued on next page)
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total proteomes of individual cell types (Aebersold and
Mann, 2016), including of naive hPSC (Di Stefano et al.,
2018). However, cell-surface proteins are typically under-
represented in these studies due to their low abundance
and biochemical properties. In response to this limitation,
several methods for measuring plasma membrane proteins
by MS have been developed (Elschenbroich et al., 2010; Jo-
sic and Clifton, 2007) that are compatible with primed
hPSC (Boheler et al., 2014; Dormeyer et al., 2008; Welde-
mariam et al., 2018).
In this study, we used plasma membrane profiling (PMP)
(Weekes et al., 2012; Zeng et al., 2009) and tandem mass
tags (TMT) (McAlister et al., 2012) to directly measure
cell-surface protein expression in naive and primed hPSC.
Our unbiased approach identified over 1,700 plasmamem-
brane proteins, including those involved in cell adhesion,
signaling, and cell interactions, thereby providing a
comprehensive stem cell proteomic resource. As a first
step toward exploring the potential role of identified cell-
surface proteins, we generated knockout cell lines for two
surface proteins that are expressed in naive hPSC, FOLR1,
and SUSD2, and sought to examine any consequences on
the acquisition of human naive pluripotency.RESULTS
Cell-Surface Proteomes of Human Pluripotent States
We used plasma membrane protein enrichment and
profiling to measure cell-surface protein expression in H9
naive and primed hPSC grown in feeder-free conditions
(Figure 1A). Aminooxy-biotinylated plasma membrane
proteins were prepared from multiple biological replicates
and captured on streptavidin beads. Proteins were digested
with trypsin and each sample was labeled with isobaric
TMT to enable accurate relative quantitation. TMT-labeled
samples were pooled, fractionated, and analyzed by MS.
Pairwise comparisons of biological replicates revealed
strong correlations between samples (average Pearson’s
correlation >0.98) (Figure S1A).
We attempted initially to harvest the cells using the non-
proteolytic reagent EDTA, but naive hPSC were resistant to
dissociation, and a brief treatment with the dissociation re-(B) Chart shows the proportion of total protein abundance for protei
ciated with all other subcellular locations (based on Uniprot Knowled
(C) Clustered heatmap shows the abundance of each measured cell-surf
each row. Primed hPSC samples are labeled according to their method
(D) Volcano plot of fold change in cell-surface protein expression and t
Hochberg correction). Dashed line indicates the q = 0.01 cutoff that
(E) Protein abundance levels for several known state-specific or share
four (primed) biological replicates and were compared using a LIMMA-
*q < 0.05, **q < 0.01, ***q < 0.001, ****q < 0.0001). See also Figu
974 Stem Cell Reports j Vol. 14 j 972–988 j May 12, 2020agent Accutase was required to dislodge the cells. As har-
vesting the cells using the enzymes contained within Accu-
tase might cleave cell-surface glycans and alter the
abundance of cell-surface proteins, we first compared the
proteomes obtained after releasing primed hPSC using
either Accutase or EDTA (Figure S1B). The vast majority of
proteins were quantitatively similar between the two con-
ditions (r2 = 0.99), and fewer than 5% of proteins differed
by more than 2-fold in expression (Figure S1C). Given
this minor effect, we harvested naive hPSC with Accutase
and combined samples to produce a high-quality dataset
of three naive hPSC replicates and four primed hPSC
replicates.
Applying cell-compartment annotations to the dataset
revealed that ~75% of the total protein abundance corre-
sponded to proteins with knownor predicted plasmamem-
brane or cell-surface localization, thereby confirming the
efficient capture of cell-surface proteins (Figure 1B). A total
of 1,715 plasmamembrane-annotated proteins were quan-
tified across naive and primed replicates. The remaining
25% of total protein abundance was derived from 4,162
proteins that are likely to interact with plasma membrane
proteins or were isolated non-specifically. Altogether, this
dataset provides a comprehensive stem cell proteomic
resource (Table S1) that can be used to understand the
cell interaction, communication, and signaling pathways
controlling human pluripotent states.We have also created
an online searchable tool for users to explore and visualize
the proteomic data (http://www.bioinformatics.babraham.
ac.uk/shiny/Wojdyla/ShinyProteomics/).
Relative quantitation of the 1,715 identified plasma
membrane-annotated proteins showed that over two-
thirds of the proteins were expressed in a cell-type-specific
manner, demonstrating that naive and primed hPSC
display distinct cell-surface proteomes (Figure 1C). Statisti-
cal analysis revealed that 518 cell-surface proteins were
more abundant in naive compared with primed hPSC,
and 636 were higher in primed (q < 0.01, LIMMA-moder-
ated t test with multiple testing correction; Figure 1D).
These sets of proteins contained several previously vali-
dated cell-surface markers. For example, naive-specific
cell-surface proteins, such as CD75, CD130, CD7, F11R,
and GPR64 were expressed at higher levels in naivens annotated as plasma membrane/cell surface and proteins asso-
geBase).
ace protein in all biological replicates. Values are normalized within
of dissociation before PMP: A, Accutase; E, EDTA.
he corresponding q value (LIMMA-moderated t test with Benjamini-
was applied to categorize differentially expressed proteins.
d cell-surface markers. Data show the mean ± SD of three (naive) or
moderated t test with Benjamini-Hochberg correction (ns, q > 0.05;
re S1 and Table S1.
(legend on next page)
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compared with primed hPSC, and CD90, HLA-A, CDH3,
PCDH1, and NLGN4X were more abundant in primed
hPSC (Figure 1E) (Collier et al., 2017; Liu et al., 2017;
O’Brien et al., 2017; Goodwin et al., 2020). Other proteins,
such as BSG, CD46, CD151, EPCAM, andCDH1 that are ex-
pressed by naive and primed hPSC were measured at
similar levels in both hPSC cell types (Figure 1E). As ex-
pected, we obtained a modest concordance when
comparing mRNA levels and protein abundance (r2 =
0.54; Figure S1D), which is in line with previous studies
that reported low correlations specifically for cell-surface
proteins (Schwanhäusser et al., 2011). The correlation
was also low when comparing our cell-surface proteome
and a previous whole-cell proteome (r2 = 0.34; Figure S1E),
which is due to the known underrepresentation and inac-
curate quantitation of cell-surface proteins that afflicts
whole-cell studies. Directly measuring plasma membrane
protein abundance overcomes these limitations.
Identification of Functional Classes
We integrated Gene Ontology (GO) terms to examine the
expression of proteins that belong to different functional
classes (Figure 2A; Table S2). The transmembrane receptor
protein tyrosine kinase (RPTK) signaling pathway was the
most significantly enriched GO term within the signaling
group (n = 91 proteins; q = 2 3 1027, Fisher’s exact test
with multiple testing correction). Interestingly, most of
these proteins were more abundant in primed than naive
hPSC, including fibroblast growth factor receptor 1
(FGFR1), insulin-like growth factor 1 receptor (IGF1R),
and most EPHRIN family members (Figure 2B). A small
set of RPTK proteins showed the opposite trend, such as in-
sulin receptor (INSR) and FGFR2, 3, and 4. In addition to
RPTKs, receptor protein-tyrosine phosphatases were highly
represented in the dataset with amore variable distribution
between naive and primed states (Figure 2B).
We next analyzed the naive and primed hPSC datasets
independently to identify cell-type-specific pathways (Fig-Figure 2. Functional Classes of State-Specific Cell-Surface Protei
(A) Scatterplot shows the GO terms that were overrepresented within
The two-dimensional space is derived by applying multidimensional sc
using REVIGO (Supek et al., 2011). Bubble size indicates the numbe
indicates the q value of the enrichment (Fisher’s exact test with Ben
(B) Heatmap shows the abundance of cell-surface-localized receptor p
Values are normalized within each row. All proteins shown are differ
proteins in gray. Significance was tested using a LIMMA-moderated
testing; q < 0.05 was classified as significantly different.
(C) Top-ranked KEGG pathways that are overrepresented within the se
(lower) along with the q value of the enrichment for each pathway (Fis
brackets refer to the number of cell-surface proteins assigned to each
(D) Protein abundance levels for detected integrins. Data show the m
were compared using a LIMMA-moderated t test with Benjamini-Hochb
Figure S2.
976 Stem Cell Reports j Vol. 14 j 972–988 j May 12, 2020ure 2C). In primed hPSC, RAP1 signaling was the most
overrepresented pathway with 49 proteins assigned (q =
2 3 1026). Notably, RAP1 activity is required for efficient
self-renewal of primed hPSC (Li et al., 2010). Following
that category, there were several GO terms related to
cellular organization and communication, including cell
adhesion molecules, focal adhesion, and tight junctions.
Unexpectedly, our quantitative data showed that nearly
all of the detected focal adhesion-associated integrins
were more abundant in primed compared with naive
hPSC (Figure 2D). Flow cytometry analysis of ITGA6
(CD49f) and ITGB1 (CD29) confirmed higher cell-surface
expression in primed compared with naive hPSC (Fig-
ure S2A). Importantly, the expression of ITGA6 and
ITGB1 was unaffected when primed hPSC were cultured
on several different substrates (Figure S2B). Interestingly,
ITGB4 was the only integrin in the proteomic dataset
that was more abundant in naive than primed hPSC (Fig-
ure 2D). ITGB4 forms a dimer with ITGA6 to interact
with laminin, and we note that laminin is one of the few
defined substrates that can successfully maintain naive
hPSC (Takashima et al., 2014).
We also examined the expression of cell-surface proteins
that are upstream of transforming growth factor b (TGF-b)
signaling, as this pathway is required for primed hPSC self-
renewal (Vallier et al., 2004). Analysis of 18 plasma mem-
brane proteins that are annotated within this pathway
showed that, overall, their expression was moderately
higher at the cell surface of primed compared with naive
hPSC. We observed this trend for receptors of Activin/
Nodal, such as ACVR2A and ACVR2B, and for TGF-b recep-
tors, such as TGFBR1 (Table S1). Interestingly, expression of
the BMP receptor BMPR2 was significantly higher in naive
hPSC (by >3-fold; q = 8 3 106). Little is known about the
effect of BMP on naive hPSC, although BMP signaling sta-
bilizes naive pluripotency of mouse cells (Morikawa et al.,
2016). The proteomic research presented here, therefore,
provides valuable information about the differences inns
the set of differentially expressed cell-surface proteins (n = 1,154).
aling to a matrix of the GO terms’ semantic similarities as calculated
r of proteins that are associated with each term and bubble color
jamini-Hochberg correction). See also Table S2.
rotein tyrosine kinases and receptor protein-tyrosine phosphatases.
entially expressed between naive and primed hPSC except for the
t test with Benjamini-Hochberg correction for multiple hypothesis
t of primed-enriched proteins (upper) and naive-enriched proteins
her’s exact test with Benjamini-Hochberg correction). The values in
pathway and the percentage coverage of each pathway.
ean ± SD of three (naive) or four (primed) biological replicates and
erg correction (ns, q > 0.05, ***q < 0.001, ****q < 0.0001). See also
(legend on next page)
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signaling and adhesion properties between human plurip-
otent states.
JAK Signaling Is Required to Establish and Maintain
Naive hPSC Proliferation and Gene Expression
Program
In contrast to primed hPSC, only a small number of identi-
fied pathways were assigned to naive-enriched proteins.
One of these pathways was cytokine-cytokine receptor
interaction (n = 19; q = 1 3 103), which contained pro-
teins, such as LIF receptor subunit alpha (LIFR), interleukin
6 signal transducer (IL6ST, CD130), and other receptors
that activate JAK-STAT signaling (Figure 2C). GO analysis
confirmed that the JAK-STAT3 signaling pathway was over-
represented among naive-enriched proteins (n = 11,
q = 0.02; Table S2).
Pathway members upstream of JAK-STAT signaling,
including CSF2RA, IL6ST, IL6R, and OSMR, showed strong
naive-specific expression at the cell surface, whereas the
abundance of other proteins, such as LIFR were only
marginally different between the two pluripotent cell types
(Figure 3A). We verified that adding LIF to primed hPSC
had no effect on IL6ST and IL6R cell-surface expression
(Figure S2C). LIF-mediated activation of JAK-STAT3
signaling is critical for the establishment and maintenance
of naivemouse pluripotent stem cells (Hall et al., 2009; van
Oosten et al., 2012); however, this requirement has not
been studied in naive hPSC cultured under stringent condi-
tions. Consistent with the differential expression of up-
stream activators of the JAK-STAT3 pathway, western blot
analysis revealed that the levels of active STAT3, marked
by Y705 phosphorylation (pSTAT3), are substantiallyFigure 3. JAK-STAT3 Signaling Is Required for Primed to Naive Re
(A) Protein abundance levels for cytokine receptors that can activate
four (primed) biological replicates and were compared using a LIMMA
****q < 0.0001).
(B) Western blot shows phosphorylated and total levels of STAT3 pro
maintained in t2iLGö on Matrigel-coated plates and primed H9 hPSC
representative of three biological replicates.
(C) Western blot confirms the decrease in phosphorylated STAT3 afte
(D) qRT-PCR analysis of gene expression levels in naive hPSC over a tim
in the top row and predicted JAK-STAT3 target genes are underneath
replicates and were compared with the 0 h time point using an AN
*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001).
(E) Prolonged JAK inhibition (dashed lines) strongly impairs the prol
(right) compared with vehicle controls (solid line). Data are shown f
(F) Flow cytometry plots of live, human cells at day 12 of primed to na
absence (Ctrl) and presence (JAKi) of JAK inhibitor. The JAK inhibitor
CD75 and SUSD2 are naive-specific markers and CD24 is a primed-specifi
in blue. Established naive and primed hPSC are shown as controls.
(G) Phase contrast images of cells at days 1 and 12 during primed t
inhibitor. Scale bar, 100 mm.
Results in (F) and (G) are representative of three biological replicate
978 Stem Cell Reports j Vol. 14 j 972–988 j May 12, 2020higher in naive compared with primed hPSC (Figure 3B).
Applying a pan-JAK inhibitor to naive hPSC caused a
decrease in pSTAT3 signal (Figure 3C).
We examined the effect of JAK inhibition and decreased
pSTAT3 levels on the expression of predicted downstream
genes in naive hPSC by time course qRT-PCR. KLF4,
ICAM1, and SOCS3 were significantly downregulated in
the presence of JAK inhibition, TFCP2L1 and GBX2 were
moderately reduced, and IER3 andCYP1B1were unaffected
(Figure 3D). Secondary effects were also observed on non-
STAT3 target genes, including a decrease in POU5F1 levels
(Figure 3D). To determine whether the gene expression
changes could be associatedwith an altered cell phenotype,
we measured cell proliferation over 5 days of JAK inhibi-
tion. We found that JAK inhibition caused a strong reduc-
tion in the number of viable naive hPSC and a modest ef-
fect on primed hPSC (Figure 3E). Finally, we investigated
whether JAK signaling is required to establish naive hPSC
by inducing primed to naive hPSC reprogramming in the
presence of a JAK inhibitor. Flow cytometry analysis
revealed that cells exposed to a JAK inhibitor failed to re-
programme to the naive state (Figure 3F) and, using phase
microscopy, we observed extensive cell death and few
naive hPSC colonies in the JAK inhibitor-treated cultures
(Figure 3G). Taken together, these results lead us to
conclude that active JAK-STAT3 signaling is required for
the establishment and maintenance of naive hPSC.
An Expanded Set of Naive-Specific Cell-Surface
Proteins
To discover new naive-specific markers, we used antibody-
based assays to examine 22 cell-surface proteins that hadprogramming and the Maintenance of Naive Pluripotency
JAK-STAT3 signaling. Data show the mean ± SD of three (naive) or
-moderated t test with Benjamini-Hochberg correction (**q < 0.01,
tein. Mass, kDa. Data in (B–E) were collected from naive H9 hPSC
maintained in TeSR-E8 on Vitronectin-coated plates. Results are
r JAK inhibition in naive hPSC. Mass, kDa.
e course of JAK inhibition. Pluripotency-associated genes are shown
(Chen et al., 2015). Data show the mean ± SD of three biological
OVA test with Dunnett’s multiple comparisons test (ns, p > 0.05;
iferation of naive hPSC (left) with a modest effect on primed hPSC
or two independent experiments.
ive hPSC reprogramming using Chemical Resetting conditions in the
was applied between days 5 and 10 at a final concentration of 1 mM.
c marker. Quadrants containing reprogrammed naive cells are boxed
o naive hPSC reprogramming in the absence and presence of JAK
s.
>3-fold increase in protein abundance in naive compared
with primed hPSC. Flow cytometry analysis of naive and
primed hPSC confirmed clear, differential expression for
12 out of 22 proteins, with well-separated cell populations.
Ten proteins were detected only at low levels or not
detected above controls, potentially due to poor compati-
bility of the antibodies with flow cytometry or the absence
of accessible epitopes. Antibody reactivity to PVR (CD155),
F3 (CD142), and CD53 produced the best separation be-
tween naive and primed hPSC populations (Figure 4),
similar to previously identified naive-specific markers,
such as CD75 and IL6ST (CD130) (Collier et al., 2017).
Additional, newly uncovered proteins, including IL6R
(CD126), INSR (CD220), LAMP1 (CD107a), ADGRE5
(CD97), IL17RA (CD217), OSMR, and CD70 gave a reason-
able separation in signal between cell types (Figure 4). We
confirmed these results using additional hPSC lines,
including the embryo-derived naive line HNES1 and the
induced PSC primed line HDF (Figure S3). Importantly,
the state-specific expression of each marker was preserved
when hPSC were cultured on different substrates,
including fibroblast cells, Matrigel, and Laminin (Fig-
ure S4). This validated set of proteins substantially
increases the number of known markers that can discrimi-
nate between naive and primed hPSC.
To investigate whether the changes in expression of the
identified markers recapitulate the developmental progres-
sion from pre-implantation to post-implantation epiblast,
we examined several published transcriptional datasets,
including hPSC capacitation (Rostovskaya et al., 2019), hu-
man epiblast cells (Xiang et al., 2020; Zhou et al., 2019),
and primate epiblast cells (Nakamura et al., 2016). This
analysis showed that transcript and protein levels corre-
lated well for several of the naive-specific markers and, of
those, genes such as IL6R, SUSD2, CD53, and FOLR1, are
downregulated during pre-implantation to post-implanta-
tion epiblast development in human and primate embryos
(Figure S5). These findings confirm that the identified
naive-specific markers generally reflect developmental
stage-specific differences in vivo.
The Folate Receptor FOLR1 Is a New Cell-Surface
Marker of Naive hPSC and Is Dispensable for Primed to
Naive hPSC Reprogramming
FOLR1 was ranked number eight on the list of naive-en-
riched proteins, with a 29-fold higher cell-surface expres-
sion in naive compared with primed hPSC (Table S1).
FOLR1 is a high-affinity folate receptor and, together
with FOLR2 and FOLR3, binds and internalizes folate,
thereby providing methyl groups for one-carbon meta-
bolism and methylation of DNA and histones (Lintas,
2019). Folate deficiency during embryonic development
is associated with neural tube defects, but there is no infor-mation about its role at the early blastocyst stage and its
impact on pluripotency. FOLR1 was the only folate recep-
tor identified within our cell-surface proteomics dataset
(Figure 5A), and we detected the expression of two folate
transporters SLC46A1 and SLC19A1 (Figure 5A). We used
an antibody to confirm naive-specific cell-surface expres-
sion of FOLR1 in multiple cell lines and growth conditions
using flow cytometry (Figures 5B and S6A) and immunoflu-
orescence microscopy (Figure 5C).
To investigate whether FOLR1 has a functional role in
naive hPSC, we used CRISPR-Cas9 to generate FOLR1-defi-
cient primed hPSC and attempted to reprogramme the
mutant cells to a naive state. After 10 days of reprogram-
ming, colonies with clear naive hPSC colony morphology
were observed in the FOLR1-deficient samples (Figure 5D).
By day 34 of reprogramming, corresponding to five pas-
sages, stable naive hPSC cultures were apparent with
dome-shapedmorphology (Figure 5D).Western blot exper-
iments and flow cytometry analysis confirmed the absence
of FOLR1 signal in FOLR1-deficient naive hPSC (Figures 5E
and 5F). Transcriptional analysis showed that FOLR3
expression was significantly higher in FOLR1-deficient
naive hPSC compared with parental controls, raising the
possibility that FOLR3 might partially compensate for the
loss of FOLR1, although this is unlikely as FOLR3 transcript
levels remained low overall (Figure S6B). FOLR2 levels were
not significantly different in the absence of FOLR1 (Fig-
ure S6B). Taken together, these results suggest that FOLR1
is not required for primed to naive hPSC reprogramming.
To characterize the FOLR1-deficient naive hPSC in more
detail, we next asked whether gene expression levels are
altered in the mutant cells. Using qRT-PCR, we observed
no difference in the expression of NANOG, SOX2,
TFCP2L1, or KLF17 between FOLR1-deficient naive hPSC
and parental controls (Figure 5G). POU5F1 and KLF4 levels
were slightly increased in the knockout cells, although
KLF4 protein levels were unchanged (Figures 5E and 5G).
Because the receptor-mediated internalization of folate
provides a methyl donor source for protein and DNA
methylation, we hypothesized that the deletion of FOLR1
could reducemethylation levels of key epigeneticmodifica-
tions. We used western blotting to measure the global
abundance of several prominent histone methylation
marks. We found there were no significant differences in
H3K27me3, H3K4me3, H3K9me3, or H3K36me3 levels be-
tween FOLR1-deficient naive hPSC compared with
parental controls (Figure 5H). Similarly, mass spectrometric
quantitation revealed there was no significant difference in
either mC or hmC levels in the FOLR1-deficient cells
compared with controls (Figure 5I). Altogether, these find-
ings reveal that FOLR1 is not required for primed to naive
hPSC reprogramming or for the maintenance of naive
pluripotency.Stem Cell Reports j Vol. 14 j 972–988 j May 12, 2020 979
Figure 4. Antibody-Based Validations Confirm Naive-Specific Expression of Cell-Surface Proteins
Histograms of flow cytometry analysis show separation between naive and primed H9 hPSC for several newly identified cell-surface
proteins. As a positive control for the assay, CD75 and IL6ST (CD130), which are naive-specific cell-surface markers, and CD57 and CD24,
which are primed-specific cell-surface markers were also examined (Collier et al., 2017). Naive H9 hPSC were maintained in t2iLGö on
Matrigel-coated plates and primed H9 hPSC maintained in TeSR-E8 on Vitronectin-coated plates. Results are representative of at least three
biological replicates. See also Figures S2–S4 and S6.
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SUSD2 Is Highly Expressed in Naive hPSC but Is Not
Required to Establish Naive Pluripotency
SUSD2 is a plasma membrane protein thought to be a
tumor suppressor acting via G1 cell-cycle arrest, but its
role in early human development is unknown. SUSD2
was number 30 on the list of naive-enriched proteins
with an 18-fold higher cell-surface expression in naive
compared with primed hPSC (Figure 6A). The SUSD2 inter-
action partner LGALS1 was also more abundant in naive
cells (Figure 6A). We confirmed the naive-specific cell-sur-
face expression of SUSD2 by flow cytometry and immuno-
fluorescence microscopy in two different hPSC lines and
multiple culture conditions (Figures 6B, 6C, and S6C). A
recent report also identified SUSD2 as a specific marker of
naive hPSC and pre-implantation epiblast cells (Breden-
kamp et al., 2019a).
As SUSD2 is highly expressed in naive hPSC, we set out to
investigate whether SUSD2 is required for primed to naive
hPSC reprogramming. We used CRISPR-Cas9 to generate
SUSD2-deficient primed hPSC. As an additional control, we
introduced an SUSD2 expression plasmid into the mutant
cell lines and confirmed that the SUSD2 signal at the cell sur-
face was similar to the levels detected in wild-type naive
hPSC (Figure S6D). We initiated primed to naive hPSC re-
programming using 5iLA conditions, and after several days
multiple colonies appeared with characteristic domed-
shaped morphology in the SUSD2-deficient and control
cell lines (Figure6D,upper).We tested if there couldbediffer-
ences in SUSD2 necessity when using an alternative reprog-
ramming protocol, however SUSD2-deficient cells wereFigure 5. FOLR1 Is Highly Expressed in Naive hPSC but Is Not Requ
Naive State
(A) Cell-surface abundance of detected folate receptors and transpor
(naive) or four (primed) biological replicates and were compared usi
(*q < 0.05, ****q < 0.0001).
(B) Flow cytometry analysis confirms higher surface-localized FOLR1
cultured in t2iLGö (naive) and E8 (primed); center left, H9 hPSC in tt2
(naive) and KnockOut serum replacement (KSR)-containing media (
(primed). Results are representative of three biological replicates.
(C) Immunofluorescent microscopy images of FOLR1-PE and DAPI signa
naive colony.
(D) Phase contrast images of FOLR1-deficient hPSC undergoing prime
(E) Non-reducing western blot confirms the absence of FOLR1 protein i
of three biological replicates.
(F) Flow cytometry analysis confirms the absence of FOLR1 signal in F
(wild-type [WT]) naive hPSC.
(G) qRT-PCR analysis of gene expression levels in parental (WT) naive h
of three biological replicates and were compared using an unpaired,
(H) Western blots show the global levels of histone modifications in p
serves as a loading control. Charts show the quantitation of western bl
replicates.
(I) Quantitation by mass spectrometry of global mC and hmC levels in
mean ± SD of three technical replicates and were compared using an
982 Stem Cell Reports j Vol. 14 j 972–988 j May 12, 2020successfully reprogrammedusingChemical Resetting condi-
tions (Figure 6D, lower). Flow cytometry analysis confirmed
the absence of the SUSD2 signal in SUSD2-deficient naive
hPSC (Figure 6E). Finally, we observed similar expression
levels of naive-specific marker genes, such as KLF4, KLF17,
and TFCP2L1, in SUSD2-deficient naive hPSC and control
cell lines (Figure 6F). Taken together, these results confirm
that SUSD2 is a specific marker of naive hPSC, but is not
required to establish naive pluripotency.DISCUSSION
Our comparative proteomic analysis showed for the first
time that the abundance of plasma membrane proteins
was quantitatively distinct between naive and primed
hPSC. Applying plasma membrane enrichment and TMT
labeling enabled the direct measurement of protein abun-
dance at the cell surface, which overcomes some of the
limitations that are associated with inferring protein
expression from transcriptional data, antibody screens,
and whole-cell proteomics. This applies particularly when
comparing cell types where transcript or whole-cell protein
levels are often not predictive of differences at the plasma
membrane due to post-translational processing. The final
dataset contains quantitative values on over 1,700 proteins
that are expressed at the cell surface, providing major ad-
vances in identifying new cell-type-specific markers and
uncovering novel target proteins with potential functional
roles in developmental and stem cell biology.ired for Primed to Naive Reprogramming or Maintenance of the
ters in naive and primed hPSC. Data show the mean ± SD of three
ng a LIMMA-moderated t test with Benjamini-Hochberg correction
expression in naive compared with primed hPSC. Left, H9 hPSC
iLGö (naive) and E8 (primed); center right, WIBR3 hPSC in tt2iLGö
primed); right, WIBR3 in 5iLA (naive) and KSR-containing media
ls. Scale bar, 100 mm. Inset shows a magnified view of an individual
d to naive 5iLA-mediated reprogramming. Scale bar, 100 mm.
n FOLR1-deficient naive hPSC. Mass, kDa. Results are representative
OLR1-deficient (knockout [KO]) naive hPSC compared with parental
PSC and FOLR1-deficient (KO) naive hPSC. Data show the mean ± SD
two-sided t test (ns, q > 0.05; *q < 0.05, **q < 0.01).
arental (WT) naive hPSC and FOLR1-deficient (KO) naive hPSC. H2B
ot fluorescence signals. Data show the mean ± SD of three technical
parental (WT) and FOLR1-deficient (KO) naive hPSC. Data show the
unpaired, two-sided t test. See also Figures S6A and S6B.
Figure 6. SUSD2 Is Highly Expressed in Naive hPSC but Is not Required for Reprogramming to Naive Pluripotent State
(A) Cell-surface abundance of SUSD2 and LGALS1. Data show the mean ± SD of three (naive) or four (primed) biological replicates and were
compared using a LIMMA-moderated t test with Benjamini-Hochberg correction (*q < 0.05, ****q < 0.0001).
(B) Flow cytometry analysis confirms higher surface-localized SUSD2 expression in naive compared with primed hPSC. Left, H9 hPSC
cultured in t2iLGö (naive) and E8 (primed); center left, H9 hPSC in tt2iLGö (naive) and E8 (primed); center right, WIBR3 hPSC in tt2iLGö
(naive) and KSR-containing media (primed); right, WIBR3 in 5iLA (naive) and KSR-containing media (primed). Results are representative
of three biological replicates.
(legend continued on next page)
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Our study provides direct validation for several cell-sur-
face proteins that are currently used to distinguish between
naive and primed hPSC (Collier et al., 2017; Liu et al., 2017;
O’Brien et al., 2017), and found additional markers that are
expressed by naive hPSC, such as F3, PVR, and CD53.
Tracking the expression of these proteins using antibodies
will provide a useful readout of naive hPSC differentiation
and reprogramming. For example, the downregulation of
CD53 expression was recently used to examine naive
hPSC differentiation during lineage specification (Linne-
berg-Agerholm et al., 2019). Notably, several of the top-
ranked naive-enriched proteins are poorly characterized,
including FAM151A and FAM174C, and their identifica-
tion provides interesting new avenues for pluripotent
stem cell research. For example, FAM174C is a recently
evolved gene present only in higher primates that encodes
a secreted protein of unknown function (Wang et al.,
2006), and so naive hPSC should provide a useful cell
model in which to study this uncharacterized protein. In
addition, we found that the surface protein CLAUDIN-6
is differentially expressed with a higher abundance in
primed compared with naive hPSC. This opens up the pos-
sibility of applying a published strategy that eliminates
CLAUDIN-6-expressing cells to selectively remove primed
hPSC from mixed pluripotent cell cultures (Ben-David
et al., 2013). This approach could be used effectively during
cell reprogramming to obtain purified populations with a
higher proportion of naive hPSC.
Our stem cell proteomic resource contains detailed infor-
mation about the expression of cell-surface ligands and re-
ceptors that is important for understanding the regulation
of cell behavior in developmental processes. One major
category of proteins that wemeasuredwas integrins, which
mediate cell-matrix and cell-cell adhesion interactions
(Harburger and Calderwood, 2009; Hynes, 2002). There
are 24 integrins in humans, which arise from the heterodi-
meric association between one of 18 a subunits and 8 b sub-
units. Different combinations of the a and b polypeptides
form complexes that vary in their ligand-binding specific-
ities. We detected nine a subunits and three b subunits in
our study. The three b subunits had interesting expression
patterns whereby b1 expression was substantially higher in(C) Immunofluorescent microscopy images of SUSD2-PE and DAPI signa
naive colony.
(D) Phase contrast images of SUSD2-deficient naive hPSC after reprog
Scale bar, 100 mm.
(E) Flow cytometry analysis confirms the absence of SUSD2 signal in
KO + SUSD2 expression (Rescue) naive hPSC.
(F) qRT-PCR analysis of gene expression levels in parental (WT), SUSD2
SD of three biological replicates and were compared using an unpaired
are from one KO and one rescue hPSC line. Similar results were obtaine
See also Figures S6C and S6D.
984 Stem Cell Reports j Vol. 14 j 972–988 j May 12, 2020primed hPSC, b4 showed the opposite pattern, and b5 was
expressed equally in both cell types. b1 interacts withmany
a subunits and typically binds to collagens, laminins, and
fibronectin. b4 binds predominantly with a6 and this het-
erodimer interacts with laminins (Chen et al., 2008; Lee,
1992) and activates several signaling molecules, including
NRG1, IGF1, IGF2, SHC1, and IRS2 (Cedano Prieto et al.,
2017; Fujita et al., 2012). In contrast, other b integrins,
including b1 and b5, activate alternative pathways, such
as FAK and ILK (Grashoff et al., 2004; Guo and Giancotti,
2004). Through these processes, integrins provide informa-
tion to the cells about their location, local environment,
adhesive state, and surrounding matrix, and transduce sig-
nals that regulate gene expression and cell growth (Gahm-
berg et al., 2009). It is possible that the cell-surface abun-
dance of integrins could be influenced by the different
substrates used for maintaining naive and primed hPSC;
however, we examined this possibility for two integrin pro-
teins and found that their expression was unaffected when
hPSC were cultured on different substrates. An important
next step will be to test the function of integrin proteins
in naive hPSC using blocking antibodies and small-mole-
cule antagonists (Byron et al., 2009). Future studies could
also use the new information on integrins and other sur-
face-localized ligand expression within our dataset to
design chemically defined substrates that are capable of
supporting naive hPSC cultures (Lambshead et al., 2018).
GO analysis of the cell-type-specific protein expression
identified several clear and unexpected functional classes.
For example, cell-surface proteins expressed in primed
hPSC were associated with RAP1 signaling. RAP1 is a small
GTPase that is required in primed hPSC for efficient self-
renewal and survival by controlling E-CADHERIN-medi-
ated cell adhesion (Li et al., 2010). The loss of cell contacts
causes the disruption of RAP1-E-CADHERIN signaling (Li
et al., 2010), and this could partly underlie the sensitivity
of primed hPSC to single-cell dissociation (Watanabe
et al., 2007). RAP1 alsomodulates a range of signaling path-
ways in many cell types (Jaskiewicz et al., 2018). It is inter-
esting, therefore, that naive hPSC express lower levels of
proteins that are associated with RAP1 signaling, suggest-
ing this pathway is not required to sustain naive hPSC.ls. Scale bar, 100 mm. Inset shows a magnified view of an individual
ramming in 5iLA (upper) or Chemical Resetting (lower) conditions.
SUSD2-deficient (KO) naive hPSC compared with parental (WT) and
-deficient (KO), and rescue (Res) naive hPSC. Data show the mean ±
, two-sided t test (ns, q > 0.05; *q < 0.05, **q < 0.01). Data in (D–F)
d from an alternative pair of KO and rescue lines (data not shown).
Notably, naive hPSC are robust to single-cell dissociation
and it will be important to investigate whether this is partly
due to the difference in RAP1 and the regulation of E-CAD-
HERIN. Conversely, the functional classes enriched within
naive-specific cell-surface proteins included mineral ab-
sorption, solute carriers, and cytokine receptor interac-
tions. In particular, plasma membrane-associated compo-
nents of the LIF-JAK-STAT3 signaling pathway were more
abundant in naive than primed hPSC, and STAT3 showed
higher activation levels. Previous studies using non-strin-
gent culture conditions have shown that hPSC acquire
LIF dependency after treatment with media containing 3i
(MEK, GSK3b, and BMP4 inhibitors) and LIF (Chan et al.,
2013), or after enforced STAT3 activity in the presence of
LIF and 2i (MEK and GSK3b inhibitors) (Chen et al.,
2015). Here, we used stringent culture conditions to show
that JAK signaling is required for the conversion of primed
to naive hPSC, and also for the stablemaintenance and pro-
liferation of established naive hPSC. Defining the down-
stream effectors of JAK-STAT3 signaling in naive hPSC is
an important line of research and the set of target factors
could be compared with emerging data in other species to
identify shared and species-specific modes of regulation
(Bernardo et al., 2018; Bourillot et al., 2020; Ramos-Ibeas
et al., 2019). Excitingly, we also detected in our proteomics
experiment the expression of multiple cytokine receptors
and ligands at the surface of naive hPSC that are currently
understudied in human pluripotency, such as OSMR,
CSF2RA, and IL10RB. Investigating the functional roles of
these cell-surface proteins in activating JAK-STAT signaling
in human pluripotent cells is a key future direction and one
that could generate more stable conditions to maintain
naive pluripotency.
FOLR1 and SUSD2 were highly ranked, naive-specific
cell-surface proteins that were identified in our proteomic
dataset. We showed that both proteins were expressed in
naive hPSC cultured under different growth conditions,
demonstrating that FOLR1 and SUSD2 can robustly and
unambiguously discriminate between naive and primed
hPSC. Tracking their expression using antibodies will pro-
vide new ways to monitor and study cell reprogramming
events. A similar observation on SUSD2 expression was re-
ported recently (Bredenkamp et al., 2019a) and the applica-
tion of this marker to reprogramming (Bredenkamp et al.,
2019b). We extended our analysis by demonstrating that
neither FOLR1 nor SUSD2 were required to establish naive
pluripotency, as knockout primed hPSC could be reprog-
rammed into a naive state. Folate endocytosis via FOLR1
provides one of the main donors of the methyl group
required for the synthesis of S-adenosylmethionine, which
in turn is needed for DNA and histonemethylation.We hy-
pothesized that DNA and histone methylation levels could
be reduced by the absence of FOLR1 in naive hPSC, howev-er, we detected unchanged levels of DNA methylation and
several histone modifications. It is possible that FOLR1
deficiency could be compensated for by one of the alterna-
tive folate transporters. Nevertheless, our discovery of
FOLR1 expression in naive hPSC opens up additional
exciting research directions, for example, by examining
whether other folate-dependent pathways, such as one-car-
bon metabolism, show differences between naive and
primed hPSC.
Our study provides an invaluable resource for stem cell
researchers by adding the cell-surface proteome as a new
layer to the molecular characterization of pluripotency,
highlighting the similarities and differences between two
human pluripotent states. The proteomic dataset could
be taken forward in several ways. Further analysis of the
identified proteins at a functional level will uncover new
pathways that control hPSC regulation. In addition, inte-
grating phosphoproteomic information to connect the
presence of receptors at the cell surface with their down-
stream signaling responses would provide amore complete
picture of regulatory pathways in human pluripotent
states.EXPERIMENTAL PROCEDURES
Cell Culture
H9, HNES1, and WIBR3 naive hPSC were maintained in t2iLGö,
PGXL, and 5iLA media (Takashima et al., 2014; Theunissen et al.,
2014; Guo et al., 2017). All naive hPSC were passaged by dissocia-
tion with Accutase every 3–4 days. H9, WIBR3, and HDF primed
hPSC were maintained in TeSR-E8 or in KnockOut serum replace-
ment-containing media. Primed cells were passaged using
0.5 mM EDTA or 200 U/mL Collagenase type IV. All hPSC were
cultured in 5% O2, 5% CO2 at 37
C. See Supplemental Experi-
mental Procedures for full details.
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